Effectiveness of Lipid-lowering therapy with Bempedoic Acid plus Ezetimibe in a Real-world Cohort

被引：0
|
作者：
Nelson, James
Bloedon, Leanne
Lewandowski, David
Bonafede, Machaon
Sarnes, Evelyn
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4131775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4131775
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients
    Toplak, Hermann
    Bilitou, Aikaterini
    Alber, Hannes
    Auer, Johann
    Clodi, Martin
    Ebenbichler, Christoph
    Fliesser-Goerzer, Evelyn
    Gelsinger, Carmen
    Hanusch, Ursula
    Ludvik, Bernhard
    Maca, Thomas
    Schober, Andreas
    Sock, Reinhard
    Speidl, Walter S.
    Stulnig, Thomas M.
    Weitgasser, Raimund
    Zirlik, Andreas
    Koch, Marina
    Wienerroither, Sebastian
    Wolowacz, Sorrel E.
    Diamand, Francoise
    Catapano, Alberico L.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (13-14) : 364 - 374
  • [12] Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis
    Perera, Kanila
    Kam, Ning
    Ademi, Zanfina
    Liew, Danny
    Zomer, Ella
    JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (06) : 772 - 783
  • [13] LIPID-LOWERING THERAPY IN CHRONIC KIDNEY DISEASE: IS THERE A ROLE FOR EZETIMIBE?
    Green, Darren
    Panayotova, Rosica
    Ritchie, James P.
    O'Riordan, Edmond
    McDonald, John
    JOURNAL OF RENAL CARE, 2012, 38 (03) : 138 - 146
  • [14] Cost effectiveness of lipid-lowering therapy: Let's get real
    Drummond, M
    PHARMACOECONOMICS, 2004, 22
  • [15] Cost effectiveness of lipid-lowering therapy: Let’s get real
    Michael Drummond
    PharmacoEconomics, 2004, 22 (Suppl 3) : i - ii
  • [16] A real-world analysis of characteristics and lipid-lowering therapy use in patients initiating treatment with evolocumab in Sweden
    Svensson, M. K.
    James, S.
    Ravn-Fischer, A.
    Pantev, E.
    Sorio-Vilela, F.
    Villa, G.
    Cars, T.
    Gustafsson, S.
    Hagstrom, E.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2590 - 2590
  • [17] Effectiveness of lipid-lowering therapy in HIV patients
    Martinez, Esteban
    Leyes, Pere
    Ros, Emilio
    CURRENT OPINION IN HIV AND AIDS, 2008, 3 (03) : 240 - 246
  • [18] Cost-effectiveness of lipid-lowering therapy
    Wendland, G
    Klever-Deichert, G
    Lauterbach, K
    HERZ, 2001, 26 (08) : 552 - 560
  • [19] Cost-effectiveness of lipid-lowering therapy
    Visseren, F. L. J.
    NETHERLANDS HEART JOURNAL, 2011, 19 (02) : 59 - 60
  • [20] Real-World Clinical Experience of Rosuvastatin as a Lipid-Lowering Therapy for Primary and Secondary Prevention of Cardiovascular Events (REAL ROSE)
    Mehta, Ashwani
    Jain, Pradeep
    Patil, Ravikant
    Kant, T. Sashi
    Indurkar, Sanjiv A.
    Kota, Sunil Kumar
    Revankar, Santosh
    Gupta, Amit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
12345